Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Nov 01, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-113183.pdf
0001104659-22-113183.rtf
0001104659-22-113183.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 01, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001558370-22-015781.pdf
0001558370-22-015781.rtf
0001558370-22-015781.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 12, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
0000899140-22-000739.pdf
0000899140-22-000739.rtf
0000899140-22-000739.xls
Oct 11, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000315066-22-001779.pdf
0000315066-22-001779.rtf
Sep 30, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-104337.pdf
0001104659-22-104337.rtf
0001104659-22-104337.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 23, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-102662.pdf
0001104659-22-102662.rtf
0001104659-22-102662.xls
Sep 21, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-101749.pdf
0001104659-22-101749.rtf
0001104659-22-101749.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 20, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-101549.pdf
0001104659-22-101549.rtf
0001104659-22-101549.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 16, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-100803.pdf
0001104659-22-100803.rtf
0001104659-22-100803.xls
Sep 12, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-099083.pdf
0001104659-22-099083.rtf
0001104659-22-099083.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2023 Intercept Pharmaceuticals, Inc.